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Various histologic classification systems have been proposed as prognostic factors for gastric cancer. We assessed the prognostic
value of Goseki classification as well as the TNM staging system, histological tumour grading, Lauren, WHO, Goseki and Siewert
classifications in 100 patients with cardia carcinoma undergoing curative surgery. Two patients were lost at follow-up. The median
time of follow-up in the remaining patients was 32.9 months after surgery (range: 0.1–142.1 months). No differences in survival rates
were observed according to tumour grading, Lauren or WHO histologic or Siewert topographical classification. No differences were
found according to Goseki classes, when considering either the mucin content of the carcinoma (types I and III vs II and IV) or the
differentiation grade (types I and II vs III and IV). Multivariate analysis showed that the only lymph node positivity was a significant
predictor of survival: 7.2% of patients with, but 41.5% of those without nodal involvement were alive after five years (P¼0.0001). In
conclusion, we found no prognostic role for Goseki or the traditional histological indexes, while the TNM staging system and
particularly lymph node positivity were the main predictors of survival in patients with cardia adenocarcinoma.
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Gastric cancer is the second most common neoplasm in the world
after lung cancer, with about 800000 new estimated cases per year
(Parkin et al, 1999). While an overall decline in gastric cancer
mortality has been observed in the USA and the European Union
since the 50’s (Nomura, 1996; Levi et al, 1999), a rising incidence of
cardia adenocarcinoma has been observed in the same areas
(Devesa et al, 1998; Botterweck et al, 2000), although some findings
suggest that these figures may be inflated by some degree of
misclassification and increased diagnostic awareness (Ekstrom
et al, 1999). However, adenocarcinoma of the cardia has different
characteristics compared to adenocarcinoma arising in the other
sites of the stomach: the male–female ratio is higher, the ethnic
background is different, a family history is less common, a past
history of chronic heartburn or duodenal ulcer is more frequent,
and there is some evidence of an association with tobacco smoking
and alcohol drinking (MacDonald and MacDonald, 1987).
Furthermore, cardia carcinoma shows a greater tendency to
proceed to deep wall penetration, is more often associated with
lymph node involvement and has a poorer prognosis than the
cancer of other gastric regions (Husemann, 1989; Maehara et al,
1991; Ohno et al, 1995; Kajiyama et al, 1997; Pinheiro et al, 1999).
Taken together, these findings support the hypothesis that cardia
adenocarcinoma may be a biologically distinct disease when
compared to adenocarcinoma arising in other stomach sites.
The histological classification systems commonly used for
gastric cancer (Lauren, 1965; Ming, 1977; Oota and Sobin, 1977)
have also been applied to adenocarcinoma of the cardia. However,
follow-up studies on the prognostic value of these indexes in
patients with cardia adenocarcinoma have provided conflicting
results (Ribeiro et al, 1981; Husemann, 1989; Maehara et al, 1991;
Jakl et al, 1995; Ohno et al, 1995; Kajiyama et al, 1997; Caldas et al,
1999; Pinheiro et al, 1999). As a consequence, new classification
systems have been suggested as prognostic factors. A grading
system that combines intracellular mucin content and tubular
differentiation has been recently proposed by Goseki et al (1992).
According to the Goseki classification, four grades of histologic
features were defined: group I) – well-differentiated tubules, poor
intracellular mucus; group II) – well-differentiated tubules, rich
intracellular mucus; group III) – poorly differentiated tubules,
poor intracellular mucus; group IV) – poorly differentiated
tubules, rich intracellular mucus. The high reliability (inter- and
intra-observer agreement) of this classification system has been
demonstrated by other research groups (Dixon et al, 1994; Songun
et al, 1999). Two recent studies found that the Goseki histological
classification was predictive of survival in patients with gastric
cancer (Martin et al, 1994; Songun et al, 1999), although two other
studies did not (Guglielmi et al, 1997; Roy et al, 1998), and thus the
prognostic value of the system remains controversial. To our
knowledge, the Goseki histologic classification has so far not been
applied in patients with cardia adenocarcinoma.
The aim of this study was to investigate the prognostic value of
Goseki classification compared with other histologic indexes used
for gastric cancer such as the conventional tumour grading (Oota
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www.bjcancer.comand Sobin, 1977), Lauren classification (Lauren, 1965), WHO
classification (Oota and Sobin, 1977), TNM staging and Siewert
topographical classification (Siewert and Stein, 1998) in a
consecutive series of patients with cardia carcinoma undergoing
potentially curative resection.
PATIENTS AND METHODS
Consecutive patients with carcinoma of the cardia who underwent
potentially curative surgical resection in the Department of
Surgery of the University of Brescia and in the Department of
Surgery of the main hospital in Cremona between 1st January 1990
and 31st December 1999 were enrolled prospectively. Among them,
58 underwent total, 33 total enlarged and 9 superior polar
gastrectomy.
The patients’ age and sex were included in the analysis. Three
categories of age were considered: o60 years, 60–90 years and
470 years. Neoplasms were staged using the pathologic TNM
system (Hermanek and Sobin, 1992). Tumour localization was
identified according to Siewert classification (Siewert and Stein,
1998): type I, adenocarcinoma of the distal oesophagus; Type II,
carcinoma of the cardia arising from the epithelium of the
oesophagogastric junction; Type III, subcardial gastric carcinoma
infiltrating the oesophagogastric junction. The histological speci-
mens were classified according to the following systems: tumour
grading, Lauren (1965), WHO (Oota and Sobin, 1977) and Goseki
et al (1992) classifications.
The end of the follow-up period was 31st October 2001. Survival
rates were calculated from the date of enrollment in the study (day
of surgical operation) up until the end of follow-up or death.
Survival curves and confidence intervals were calculated according
to the method of Kaplan and Meier (1958). Comparisons among
groups were performed using common statistical tests for
proportion analysis and the log-rank test for univariate analysis.
Cox’s (1972) regression models were fitted to evaluate the
prognostic significance of the TNM staging system, tumour cell
differentiation, Lauren, WHO and Goseki histological classification
of the neoplasm, Siewert classification, and patients age and sex,
adjusting the effect of any factor for each other. The prognostic
value of the Goseki histologic system was further investigated
among patients with less advanced neoplasms according to TNM
classification. Statistical tests were two-sided and a P-value of 0.05
was used for rejecting the null hypothesis. All the analyses were
performed using the STATA statistical program for a personal
computer (Stata Statistical Software: Release 7.0. College Station,
Stata Corporation, TX, USA).
RESULTS
A total of 100 patients, 76 males and 24 females, of mean age 66.3
years (standard deviation (s.d.): 9.3 years; range: 41–86 years)
underwent curative resection for adenocarcinoma of the cardia
and were enrolled in the study. The main histopathological
findings of the tumours and the corresponding 5-year survival
rates are reported in Table 1. Most neoplasms were of the intestinal
types according to Lauren classification, papillary or undiffer-
entiated cancers according to the WHO classification, medium or
poorly differentiated according to the grading system, and Goseki’s
types I or II. According to TNM classification, most neoplasms
were at an advanced stage, with only a minority of neoplasms in Tl
or N0 or stage I. With respect to topographical characteristics, 54%
of tumours were within 1cm oral and 2cm aboral of the
gastroesophageal junction (type II according to Siewert’s classifi-
cation), 41% were subcardial (types III) and only 5% were in the
distal oesophagus (types I).
Two patients were lost at follow-up. Among the 98 who
completed the follow-up, 68 died, 7 of whom within 30 days after
surgery owing to complications. Among the 30 patients who were
still alive at the end of the follow-up, 18 survived at least 5 years
after surgery (18.4% of the total who completed the follow-up). As
shown in Table 1, the 5-year survival rates showed substantial
variations according to TNM staging (from 43.2% in stage I to
8.6% in stage III) and grading (from 55.6 to 16.7%), and less
relevant differences according to the other factors. The median
survival time was 32.9 months (range: 0.1–142.1 months); it was
longer in females (59.2 months) than in males (24.9 months)
(P¼0.03) but did not vary with age (59.2 months in patients aged
less than 60 years, 45.1 months in those aged 60–69 and 44.0
months among those older than 70 years; P¼0.4).
The local infiltration depth (T) and nodal involvement (N) were
both of prognostic value in univariate analysis. Survival curves
according to pathologic T (pT stage) (Figure 1) showed a better
survival of patients with Tl stage tumours than those with more
advanced cancer (T2–T4) (median survival times of 71.6 and 25.4
months, respectively, P¼0.04), with no differences among patients
with T2, T3 or T4 stage tumours. After 5 years, 52.6% of patients
Table 1 Distribution of patients with carcinoma of the cardia (n=100)
according to Siewert topographical and various histological classification
systems and 5-year survival rate (%)
Classification of tumours No. 5-year survival rate (%)
Lauren classification
Intestinal 83 24.1
Diffuse 13 6.3
Mixed 3 0
WHO classification
Papillary 49 20.8
Tubular 7 42.9
Mucinous 9 11.1
Signet ring cell 18 23.5
Undifferentiated 17 17.7
Grading
Well differentiated 9 55.6
Medium differentiated 48 19.2
Poorly differentiated 43 16.7
Goseki classification
Type I 34 26.5
Type II 33 18.8
Type III 20 26.3
Type IV 13 7.7
TNM staging
T
T1 20 52.6
T2 45 20.5
T3 22 4.6
T4 13 7.7
N
NO 43 41.5
N+ 57 7.0
Stage
Stage I 39 43.2
Stage II 25 8
Stage III 35 8.6
Stage IV 1 0
Siewert classification
Type I 5 40
Type II 54 19.2
Type III 41 22
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402with Tl cancer but only 11.4% of those with T2–T4 cancer were
still alive (w
2-test: P¼0.0003). A significant difference in survival
was also found according to lymph node involvement (Figure 2):
41.5% of patients with lymph node negative cancer but only 7% of
those with lymph node positive cancer were alive after 5 years (w
2 -
test: P¼0.0001). The TNM staging system was an independent
prognostic variable: stage I showed a median survival of 60.8
months, stage II of 31.7 months and stage III of 19.3 months, with
highly significant differences in survival curves (P¼0.001) after
excluding the single patient with a stage IV neoplasm (Figure 3).
According to conventional tumour grading, survival curves
showed differences between patients with Gl grade compared to
the others, although they were not significant because of the small
number of deaths in the former group (n¼3) (P¼0.5) (data not
shown). According to the Lauren classification, neoplasms of the
intestinal type showed a longer median survival time (33.0
months) than the diffuse (21.8 months) and mixed types (26.5
months), although the differences were not significant (P¼0.7)
(data not shown). Again, no difference was observed in survival
according to the WHO classification: the median survival time
observed was 24.4 months for papillary adenocarcinoma, 44.4
months for tubular cancer, 32.7 months for mucinous cancer, 28.1
for signet ring neoplasm and 27.0 (P¼0.9) for poorly differ-
entiated cancer (data not shown). Similarly, no statistically
significant difference in survival was found between types I, II
and III tumours according to the Siewert topographical classifica-
tion, the 5-year survival rate being 40, 17.3 and 17.1%, respectively
(data not shown).
No differences in survival were observed for the different Goseki
classes (Figure 4): median survival times were 32.0 months for
types I, 25.0 months for type II, 36.4 months for type III and 23.7
months for type IV (P¼0.9). In order to assess the prognostic
value of the mucin content of the carcinoma, we compared Goseki
types I and III with Goseki types II and IV. No significant
difference was observed: the median survival time of the ‘poor
intracellular mucus’ groups (types I and III) was 33.7 months and
that of the ‘rich intracellular mucus’ groups (types III and IV) was
25.3 months (P¼0.5). To investigate the role of the differentiation
grade in Goseki classification, well-differentiated cancer (types I
and II) and poorly differentiated cancer (types III and IV) were
grouped and compared. Again, no statistically significant differ-
ence in survival time was observed (P¼0.7).
We investigated the role of each variable adjusting for the others
(sex, age, TNM staging system, histological tumour grading, and
Lauren, WHO, Goseki and Siewert classifications) fitting Cox’s
proportional hazards models. Multivariate analysis showed that
only lymph node positivity was a statistically significant predictor
of survival, with a hazard ratio of 3.2 (95% confidence interval:
1.8–5.8) for patients with positive nodes compared to patients
with negative nodes. Sex and age were not associated with survival
when including TNM staging. Furthermore, the T stage was
strongly associated with lymph node positivity, and the indepen-
dent role of each of them could not be assessed properly. In fact,
only two of 57 (3.5%) patients with lymph node involvement, but
18 of the 43 (41.9%) without it, had a more than Tl stage. A
stratified analysis according to age categories and sex did not
reveal any substantial differences: lymph node positivity remained
the only significant predictor of survival in each analysis. Finally,
subgroup analysis was performed for Goseki classification
according to patients’ sex and age and TNM staging and for
Siewert classification, but no association with survival was found.
A separate analysis showed no difference in survival rates
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Figure 1 Survival curves according to T stage.
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403according to Goseki classification when restricted to the 54
patients with Siewert types n cancer only.
DISCUSSION
The adenocarcinoma of the cardia generally has a low curative
resection rate and a poor prognosis, worse than carcinoma of the
other regions of the stomach, mostly because of the more advanced
stage of the disease at diagnosis (Husemann, 1989; Maehara et al,
1991; Ohno et al, 1995; Kajiyama et al, 1997; Pinheiro et al, 1999).
The 5-year survival rate in resected cases has been found to be 20%
or less (Graham et al, 1998).
Among the many characteristics investigated, only the TNM
stage consistently proved to be of prognostic value (Maehara et al,
1991; Kajiyama et al, 1997; Graham et al, 1998). Of the newer
systems proposed, the Goseki classification is one of the most
promising prognostic factors. It is based on two cancer features:
tubular differentiation and the degree of mucus production by the
tumour cells. Previous reports have suggested that mucus
production could be of greater importance than tubular differ-
entiation in the assessment of prognosis (Goseki et al, 1992; Martin
et al, 1994; Songun et al, 1999). Mucins are heavily glycosylated
glycoproteins that are the main components of the mucous viscous
gel covering the surface of epithelial tissues. Changes in the
expression levels and glycosylation patterns of mucins have been
associated with several diseases, including carcinomas (Sakamoto
et al, 1997; Reis et al, 1999). Alteration in mucin expression has
been reported (Sakamoto et al, 1997) and such abnormality was
proposed as a potentially informative molecular marker of
increased risk of malignant transformation in intestinal metaplasia
(Reis et al, 1999). In 1971, Paile first reported a significantly poorer
survival rate in patients with mucus-rich tumours (Paile, 1971),
and two later reports demonstrated that signet ring carcinomas,
which are rich in intracellular mucus, have a worse prognosis than
well-differentiated carcinomas sitting in lakes of extracellular
mucus (Brander et al, 1974; Ishii et al, 1981).
The prognostic value of Goseki classification has been evaluated
in only a few studies in patients with gastric cancer with
contradictory results (Martin et al, 1994; Dixon et al, 1994;
Guglielmi et al, 1997; Roy et al, 1998; Songun et al, 1999), although
some authors have suggested selecting patients for adjuvant
therapy after curative resection of cancer according to the Goseki
classification (Martin et al, 1994).
We aimed to assess the prognostic value of Goseki histological
classification compared to other histological and Siewert topo-
graphical classification systems in patients undergoing curative
surgery for cardia adenocarcinoma. Overall, this study confirmed a
poor prognosis for patients with cardia adenocarcinoma, with only
18.4% surviving for 5 years after surgery. We enrolled a relatively
small number of patients with a complete follow-up (n¼98),
which means the study did not have much statistical power to
show significant differences in survival according to various
factors. However, this is the first study assessing the role of Goseki
and other prognostic factors in the survival of patients with cardia
carcinoma, which is usually considered a clinical entity distinct
from gastric carcinoma (Husemann, 1989), and it should therefore
be regarded as tentative.
We did not find any prognostic role for either Goseki or other
histological classification systems, patients’ age, sex or Siewert
topographical classification. According to Goseki classification, it
should be noted that somewhat inconsistent results were shown by
the two independent studies finding significant differences in
survival of patients with gastric carcinoma (Martin et al, 1994;
Songun et al, 1999). The 5-year survival rates or median survival
times varied according to Goseki grades in different ways in the
two studies: Martin et al (1994) observed longer survival in Goseki
grade III when compared with grade IV patients, while the
contrary was found by Songun et al (1999). It is also noteworthy
that Songun et al (1999) found a weak association between Goseki
classification and survival of patients with gastric carcinoma, with
a hazard ratio of 1.5 for Goseki stage III vs I+IV, whereas the risk
of dying according to TNM stage reached a peak of 8.2 for patients
in the most unfavourable stage. Therefore, although our study
cannot be considered conclusive because of its small size and
further research is mandatory, when taken together the present
findings do not support the hypothesis that relevant differences in
survival exist in patients with cardia adenocarcinoma according to
Goseki classification.
With respect to the other prognostic factors investigated, our
study shows that, in the absence of distant metastases, only lymph
node involvement (N) is a statistically significant prognostic factor
for cardia carcinoma in patients undergoing curative surgery,
when taking account of the other factors as well. Deep wall
invasion (local infiltration depth, T) was no longer significant after
considering lymph node involvement, contrary to evidence from
another study showing local infiltration depth but not node
involvement as predictive of survival (Jakl et al, 1995). However, it
is well known that these two factors are strongly related and
therefore it is difficult to disentangle the role of each of them.
Accordingly, histological grading was associated with other
prognostic indexes, particularly lymph node positivity, since none
of the 9 patients with well-differentiated carcinoma had node
positivity, in contrast with 74.4% of the 43 with poorly
differentiated types. We also found that the Siewert topographical
classification was of no prognostic value, although only 5
subjects were classified as types I, thus preventing proper
comparisons between this group and the others.
In conclusion, we found no prognostic role for Goseki or other
traditional histological classification systems or for Siewert
topographical classification; however, we did confirm the relevance
of the TNM staging system as the most important predictor of
survival in patients with adenocarcinoma of the cardia.
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